EULAV Asset Management
Q4 2020 13F-HR Holdings
Net value change ($000)
+434,455
(12.8%)
New positions
3
Sold out positions
13
Turnover %
1.6%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q3 2020
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| TDY | 19,731 | 26.4% |
| TDG | 14,495 | 30.3% |
| Global Blood Therapeutics, Inc. | 13,859 | NEW |
| RNG | 13,057 | 53.5% |
| CDNS | 12,902 | 28.0% |
| FICO | 12,538 | 34.0% |
| NOW | 11,484 | 21.9% |
| VRSK | 11,146 | 113.5% |
| ICE | 10,606 | 43.8% |
| ADBE | 10,568 | 25.7% |
Top Reduces (Value $000, Stocks/ETFs)
| NOC | -17,145 | -57.1% |
| Slack Technologies, Inc. | -13,699 | -100.0% |
| ACN | -13,025 | -23.5% |
| ADP | -10,900 | -50.8% |
| BMRN | -10,195 | -100.0% |
| CRM | -8,268 | -12.1% |
| MTD | -7,953 | -13.6% |
| VRSN | -6,043 | -100.0% |
| OTEX | -4,251 | -72.8% |
| PROOFPOINT INC | -3,789 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|